B. IV magnesium sulphate – Explanation
Current guidelines do not support the routine use of non-invasive ventilation in asthmatics.
Asthma: acute severe
Patients with acute severe asthma are stratified into moderate, severe or life-threatening
Moderate | Severe | Life-threatening |
• PEF > 50% best or predicted • Speech normal • RR < 25 / min • Pulse < 110 bpm1 |
• PEF 33 – 50% best or predicted • Can’t complete sentences • RR > 25/min • Pulse > 110 bpm |
• PEF < 33% best or predicted • Oxygen sats < 92% • Silent chest, cyanosis or feeble respiratory effort • Bradycardia, dysrhythmia or hypotension • Exhaustion, confusion or coma |
British Thoracic Society guidelines
- magnesium sulphate recommended as next step for patients who are not responding (e.g. 1.2 – 2g
IV over 20 mins) - little evidence to support use of IV aminophylline (although still mentioned in management plans)
- if no response consider IV salbutamol